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A B S T R A C T
Background: Little is known about how daily life mood reactivity to minor stressors (stress reactivity)
might change following major depressive disorder (MDD) treatment. We investigate whether (i) mood
states and appraisals of daily stressors change after treatment; (ii) stress reactivity to event, activity, or
social stress differs; (iii) stress reactivity depends on severity of residual depressive symptoms; and (iv)
stress reactivity in individuals with remitted or non-remitted depression differ from that of never-
depressed individuals.
Methods: Thirty depressed individuals participated in an experience sampling study before and after a
treatment period of 18 months; 39 healthy individuals formed a comparison group. Reactivity of positive
affect (PA) and negative affect (NA) to daily stressors were measured.
Results: More residual symptoms were associated with larger NA responses to stress. Compared to
healthy controls, participants with non-remitted MDD showed higher NA-reactivity to all stressors. In
contrast, stress reactivity to event and activity stressors was normalized in remitted patients. However,
they still showed heightened NA-reactivity to social stress.
Conclusions: Greater stress reactivity to event and activity stress appears to be state-dependent. The
heightened social stress reactivity in remitted patients suggests that sensitivity to social stress may
reﬂect an underlying vulnerability in MDD.
 2015 Elsevier Masson SAS. All rights reserved.
Contents lists available at ScienceDirect
European Psychiatry
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Major depressive disorder (MDD) is characterized by persistent
low mood and loss of interest or pleasure in normally enjoyable
activities, reﬂected in high levels of negative affect (NA) and low
levels of positive affect (PA) [12]. MDD is further characterized by
high rates of relapse and recurrence [7,17], even in patients
receiving treatment [38].
Alterations in mood reactivity to stressors (stress reactivity) in
MDD have been examined by two broad methodological strategies.
First, most studies that examined mood responses to experimental
stressors reported blunted reactivity to negative (and positive)
events, giving support for the Emotion Context Insensitivity (ECI)* Corresponding author. Department of Psychiatry and Neuropsychology, School
for Mental Health and Neuroscience, South Limburg Mental Health Research and
Teaching Network, EURON, Maastricht University, PO Box 616, 6200 MD
Maastricht, The Netherlands. Tel.: +0031 433299631.
E-mail address: mark.vanwinkel@maastrichtuniversity.nl (M. van Winkel).
http://dx.doi.org/10.1016/j.eurpsy.2015.02.011
0924-9338/ 2015 Elsevier Masson SAS. All rights reserved.theory [9,36]. A second approach consists of examining mood
reactivity to minor stressors in daily life with the use of ecological
momentary assessment techniques like the experience sampling
method (ESM) [16,14]. Until now, ESM studies have focused on
stress reactivity to three different types of stressors; event stress
(stress reactivity following small events), activity stress (reactivity
while appraising current activities), and social stress (reactivity
associated with the appraisal of current interpersonal context).
First, some studies examined mood alterations following small
negative events [10,32,41]. Peeters et al. (2003) reported blunted
stress responses (i.e., smaller increases in NA and smaller
decreases in PA) following negative events in depressed partici-
pants compared to a healthy comparison group. In contrast,
Bylsma et al. (2011) and Thompson et al. (2012) found no
differences between depressed and healthy participants in either
PA or NA-reactivity to negative events. Two other studies
investigated stress reactivity to activity-related stress, operatio-
nalized as unfavorable appraisals of the current activity
[44,31]. Using data from the sample described by Peeters et al.
M. van Winkel et al. / European Psychiatry 30 (2015) 441–447442(2003), Myin-Germeys et al. (2003) found increased NA-reactivity
to activity stress in depressed participants, compared to healthy
controls. A similar pattern was found in a comparison of depressed
participants that were about to participate in an imipramine
treatment and healthy controls [44]. Finally, stress reactivity has
been investigated in relation to social stress. This is relevant for
MDD, as much research has shown that social stress puts people at
risk for the development or recurrence of MDD [4,13,43,42]. A
body of literature also supports the notion that depressed
individuals often experience being in social situations as highly
stressful [20,23], resulting in feelings of entrapment and the wish
to escape [19]. In the ESM study by Myin-Germeys et al. (2003)
mentioned above, social stress in daily life was assessed by asking
participants to what extent they would rather be alone than in the
present company. The desire to be alone was associated with
larger increases in NA in depressed compared to healthy
participants, interpreted as increased reactivity to social stress
in MDD.
However, little is known about changes in daily life stress
reactivity following treatment. Insight into differences in daily life
stress reactivity among individuals with remitted versus non-
remitted MDD, as compared to healthy, never-depressed individ-
uals, may help elucidate the mechanism through which daily
stress is linked to episodes of MDD, remission, and risk for
recurrence. Next, it remains unclear whether clinical improve-
ment is accompanied by normalization of daily stress reactivity.
To our knowledge, only one study in MDD has examined post-
treatment changes in mood reactivity to daily stress. Sixty-three
depressed patients took part in an ESM study prior to and again
after six weeks of treatment with imipramine or placebo [44]. NA-
reactivity to daily stressors at baseline decreased after six weeks
in both the placebo and the imipramine arm, with more
pronounced changes in the active treatment group. However, it
is not known whether this change in NA-reactivity would be
sustained over a longer period of treatment, or following
remission. Finally, we do not know whether mood reactivity to
stressors in depressed individuals who do not proﬁt from
treatment and thus develop a more chronic condition differs
from that of individuals with remitted MDD. This is clinically
relevant, as a myriad of studies have shown that treatment
efﬁcacy decreases when MDD becomes more chronic [15]. A
prolonged episode of MDD might hypothetically inﬂuence stress
reactivity in ways that make depressed individuals more resistant
to therapeutic interventions.
Aims of the study:
 do momentary mood states, negative event frequencies, and
appraisals of stress, current activities, and social company
change after standard MDD treatment?
 does post-treatment stress reactivity differ according to the type
of daily stressor (event, activity, or social stress)?
 does stress reactivity differ in relation to the severity of residual
depressive symptoms after treatment?
 does stress reactivity in individuals with remitted or non-
remitted depression differ from that of healthy, never-depressed
individuals in daily life?
2. Methods
This study is a follow-up extension of an earlier study by
Peeters et al. [32]. In this study, mood reactivity to small events in
daily life was examined in clinically depressed participants with
the use of ESM prior to treatment. Mood reactivity of depressed
participants was compared with those of healthy controls. For
details about participants and treatment procedure, see [32] and
[33], respectively.2.1. Participants
Forty-six participants fulﬁlling Diagnostic and Statistical
Manual of Mental Disorders (4th ed., DSM–IV)[3] criteria for
MDD as their primary diagnosis, as assessed with the Structured
Clinical Interview for DSM-IV (SCID; [18] by a research psychiatrist
(FP)). Participants were recruited among subjects seeking treat-
ment at a university-afﬁliated mental health centre or the
outpatient department of a psychiatric hospital in Maastricht,
the Netherlands. Exclusion criteria were current substance abuse
or psychotic symptoms (both assessed with the SCID) and
insufﬁcient ﬂuency in Dutch. None of the participants was using
antidepressants during the pre-treatment (baseline) measure-
ment, but use of low-dose anxiolytic drugs was allowed. Thirty-
nine healthy participants, matched as a group to the patient
sample for gender and age, were recruited from available research
pools, through staff from academic afﬁliations, and an advertise-
ment in a local newspaper. Additional exclusion criteria for the
healthy participants were a lifetime history of any DSM-IV[3] Axis I
disorder (assessed with the initial screening section of the SCID)
[18] or any inpatient treatment for an Axis I disorder in a ﬁrst-
degree relative.
Depressed and control participants took part in an experience
sampling (ESM) procedure for six days at baseline. Immediately
thereafter, all depressed participants entered a naturalistic
treatment phase that consisted of pharmacotherapy and support-
ive psychotherapy, according to current practice guidelines. After
18 months, 30 of the initial 46 depressed participants agreed to
take part in a second ESM period. Clinical outcome at 18 months
was measured with the Hamilton Depression Rating Scale (HDRS;
[22], with remission deﬁned as an HDRS score  7 [46]). Control
participants didn’t take part in this second ESM assessment.
Participants in the follow-up study did not signiﬁcantly differ from
non-participants with respect to gender (female) (56.6% vs 60%;
z = 0.213, P = 0.831), symptom severity (HDRS score) (24.2 vs 23.6;
t(43) = –0.426, P = 0.672), benzodiazepine use (10% vs 0%; z =
–1.31, P = 0.191), previous episodes (50% vs 20%; z = 1.936,
P = 0.053) or positive family history (56.6% vs 53.3%; z = 0.212,
P = 0.832), as assessed at baseline. The study was approved by the
local medical ethics committee, and written informed consent was
obtained from all participants. Participants were paid $30 for
completing the study.
2.2. Experience sampling method
The ESM was used to collect data from participants at selected
moments during their daily activities. Participants received a
digital wristwatch and a set of ESM self-assessment forms collated
in a booklet for each day. The wristwatch was programmed to emit
a signal (‘‘beep’’) at an unpredictable moment in each of ten 90-
minute time blocks between 7:30 and 22:30, on six consecutive
days, resulting in a maximum of 60 beeps per person. After each
beep, participants ﬁlled out an ESM self-assessment form,
including ratings of current mood and context. Participants were
instructed to complete their reports immediately after the beep,
thus minimizing memory distortion, and to record the time at
which they completed the form. Reports not completed within
25 min after the actual beep were considered invalid. Participants
with fewer than 20 valid reports were excluded from the analysis.
All follow-up participants met our inclusion criteria of submitting
at least 20 valid reports.
At baseline, participants completed an average of 85% of all
possible responses within the time limit, resulting in an average
number of valid responses of 50.7 per participant. Mean time
between prompt and response (in minutes) was lower in the
healthy (M = 4.67, SD = 2.12), than in the depressed group at
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ber of valid responses was higher in the healthy (M = 53.1,
SD = 4.87) than in the depressed group (M = 48.6, SD = 7.49),
t(83) = 3.23, P = 0.002. Mean number of valid social stress
responses was 70% of the maximum possible responses within
the time limit. Mean number of valid social stress responses in the
healthy group (M = 39.7, SD = 11.1) was similar to depressed group
(M = 33.8, SD = 14.8), t(83) = 1.18, P = 0.239.
At follow-up, participants completed an average of 81% of all
possible responses within the time limit. Mean number of valid
responses in the remitted group (M = 50.9, SD = 7.98) was similar
to the non-remitted group (M = 47.2, SD = 8.53), t(28) = –1.17,
P = 0.252. Mean time between prompt and response (in minutes)
in the remitted group (M = 6.16, SD = 4.08) was also similar to the
non-remitted group (M = 6.72, SD = 3.16), t(28) = 0.41, P = 0.681.
At follow-up, mean number of valid social stress response was
58% of all possible responses within the time limit. Mean number
of valid social stress responses in the remitted group (M = 39.4,
SD = 12.55) was similar to the non-remitted group (M = 32.1,
SD = 11.89), t(28) = –1.59, P = 0.123.
2.3. Measures of momentary mood
Mood states were assessed at each beep with 20 adjectives
rated on 7-point scales (1 ‘‘not at all’’ to 7 ‘‘very’’). Principal
components analyses of baseline data, with varimax rotation on
mean scores aggregated per person and on within-person z-scores,
identiﬁed two factors with Eigen values greater than 1. These
factors accounted for 81% of the total between-person variance in
mean mood levels and 46% of the within-person variance in mood
states. Ratings on the items anxious, irritated, restless, tense,
guilty, edgy, distractible, and agitated were averaged to form a
negative affect (NA) scale (Cronbach’s a = 0.95). Ratings on the
items energetic, enthusiastic, happy, cheerful, talkative, strong,
satisﬁed, and self-assured were averaged to form a positive affect
(PA) scale (Cronbach’s a = 0.97). The items gloomy, lonely, tired,
and calm had similar loadings on each of the two factors and were
therefore excluded from the NA and PA scales.
2.4. Measures of stress
2.4.1. Daily life stress was measured in three different ways
2.4.1.1. Event stress. After each beep, subjects responded to the
question ‘‘Did you experience a negative event or situation since the
previous beep?’’. Participants who answered afﬁrmatively were
asked brieﬂy to describe the event in their ESM booklet and to rate
the event on three appraisal dimensions: stressfulness, unpleasant-
ness, and importance (single items, from 1 ‘‘not at all’’ to 7 ‘‘very
much’’). For the current paper, event stress was deﬁned as the
occurrence of a negative event in the preceding interval, scored 1
(yes) or 0 (no). Although participants were instructed to report only
external events or situations that actually took place in their daily
environment in the preceding interval, some event reports clearly
referred to internal states (e.g., current ruminations about past
events, personal health concerns). Following pre-established crite-
ria, the research team identiﬁed such internal events by consensus
and omitted them from subsequent analyses, to avoid confounding
of event and mood measures.
2.4.1.2. Activity stress. After each beep, participants rated three
aspects of their current activity (from 1 ‘‘not at all’’ to 7 ‘‘very
much’’). The activity stress score was calculated as the mean rating
for the items ‘‘I am not skilled at this activity’’, ‘‘This activity
requires effort’’, and ‘‘I enjoy this activity’’ (reverse-coded so that
high scores reﬂect lack of enjoyment) (Cronbach’s a = 0.83).2.4.1.3. Social stress. Social stress was operationalized as the
extent to which an individual would rather be alone than in the
present company. If participants indicated being with others at the
moment of the beep, they were then asked to rate how much they
would have preferred to be alone on a 7-point scale ranging from
1 ‘‘not at all’’ to 7 ‘‘very much’’. The intraclass correlation
coefﬁcient (ICC) of social stress on the subject level is 0.96 and
at the beep level 0.85.
2.5. Statistical approach
To examine pre- to post-treatment changes in stress and mood
states in the initially depressed but non-remitted participants at
follow-up, we used paired t-tests to compare individuals’ event
frequencies and mean ratings for event stress, activity stress, social
stress, PA and NA at follow-up versus baseline. We next compared
these measures between remitted participants at follow-up and
healthy controls with a two sample unpaired t-test.
Because ESM data have a hierarchical structure, with multiple
observations (level 1) clustered within days (level 2) within subjects
(level 3), further analyses were performed with multilevel regres-
sion modelling, which takes the variability associated with each
level into account [40]. The dependent variable was either NA or PA.
The Stata v.12.1 procedure XTMIXED [26] was used to estimate ﬁxed
effects, with random intercepts, random slopes, and an unstructured
covariance matrix applied, in order to avoid inference bias that could
inﬂate the type I error rate. For signiﬁcant interactions (non-
remitted versus healthy controls and remitted versus healthy
controls), stratiﬁed analyses were conducted to clarify group
differences. Further, effect sizes of the interactions between the
groups and appraised social stress were calculated by applying and
testing the appropriate linear combinations using the STATA
LINCOM command. These effect sizes were used to graphically
illustrate group differences at each level of social stress (from ‘‘not at
all’’ until ‘‘very much’’). Standard errors were calculated for each
level of social stress and were depicted in the ﬁgure with error bars.
A signiﬁcance level of P < 0.05 was used (two-sided tests). In
order to use negative events as a predictor in the model, they were
dummy-coded (0 or 1). The event appraisal scores were centered
around the grand mean or were set to zero if no event was
reported, so that inclusion in the model would not automatically
change the previously estimated effects of events on mood.
We examined stress reactivity at 18-month follow-up by
estimating (in separate models) the effects of event stress, activity
stress, and social stress on NA and PA. Further, by testing
interactions between each of the three types of stress and the
HDRS score, we investigated whether changes in daily life stress
reactivity were related to the severity of residual depressive
symptoms post-treatment. Last, we compared stress reactivity to
negative events, activity stress, and social stress in remitted and
non-remitted patient groups with that in the healthy comparison
group. To do this, we estimated multilevel models with mood state
as outcome and, as predictors, group, stress (event, activity, or
social), and the group by stress interaction.
3. Results
3.1. Clinical characteristics of the MDD sample at follow-up
Among the 30 depressed participants (of whom 17 women),
mean HDRS score was signiﬁcantly lower at post-treatment follow-
up (M = 10.8, SD = 7.8) compared to baseline (M = 24.2, SD = 4.1), t
(29) = 8.2, P < 0.001. At follow-up, 11 of the 30 participants met the
remission criterion (HDRS score  7). Ten participants were still
using antidepressants; two used benzodiazepines. In Table 1,
characteristics of remitted and non-remitted MDD participants at
Table 1
Subject characteristics of depressed participants pre- and post-treatment.
Pre-treatment Post-treatment
Variable Depressed Non-remitted
at FU
Remitted
at FU
n 30 19 11
Men
Women
13
17
7
12
6
5
Age in years 40 41 39
HDRS 24.2 15.1 3.2a
BDI 28.1 21.6 8a
Positive family history (%) 56 58 54
Previous episode(s) (%) 50 42 63
a Differences between remitted and non-remitted participants at follow-up:
P  0.001; bDifferences between remitted and non-remitted participants at follow-
up: P  0.05.
M. van Winkel et al. / European Psychiatry 30 (2015) 441–447444follow-up are compared. Remitted MDD participants do not differ
from non-remitted MDD participants in gender, age, positive family
history of MDD and previous episode(s).
3.2. Daily stressors
Frequencies and appraisals of events and mean levels of stress
in all groups (baseline MDD, remitted at follow-up, non-remitted
at follow-up, and healthy controls) are presented in Table 2.
In total, 32 out of 180 (17.8%) negative events were considered to
be internal negative events and therefore excluded from analyses.
Frequencies, the appraised unpleasantness of negative events and
level of social stress in non-remitted participants did not change
from pre- to post-treatment (Table 2). The appraised importance and
stressfulness of negative events and the mean level of activity stress
decreased signiﬁcantly in non-remitted participants from pre- to
post-treatment. The experience of daily stressors in remitted
participants was no longer signiﬁcantly different from that of
healthy controls, in terms of appraised stressfulness or importance
of negative events or in levels of activity stress or social stress;
however, remitted patients appraised negative events as more
unpleasant, compared to controls (Table 2).
3.3. Momentary mood states after treatment
Mean PA in non-remitted participants was unchanged at
follow-up compared to baseline (2.5 vs 2.1, t (18) = –2.62, P = 0.09).Table 2
Comparison of frequencies (%) and appraisals (mean/SD) of reported negative
events and mean ratings of social stress and activity stress.
Type of stress Depressed at
baseline (and
non-remitted
at FU)
(n = 19)
Non-remitted
at FU
(n = 19)
Remitted
at FU
(n = 11)
Healthy
(n = 39)
Negative eventsa
Unpleasant
Important
Stressful
16%
5.9 (0.7)
5.1 (1.1)
5.8 (0.9)
12%
5.6 (0.8)
3.9 (1.7)#
5.2 (1.0)#
9%
5.5 (0.8)
5.0 (1.4)
4.2 (0.9)
16%
4.7 (0.9)*
4.0 (1.2)
3.3 (1.2)
Activity stress 3.8 (0.5) 3.5 (0.7)# 2.9 (0.7) 2.5 (1.1)
Social stress 2.2 (1.1) 2.6 (1.4) 1.7 (0.5) 1.5 (1.3)
Note: frequencies and appraisals of negative events, levels of social stress and
activity stress are compared between: MDD participants at baseline and non-
remitted at 18-month follow-up and remitted versus healthy controls.
Differences between non-remitted participants at follow-up and depressed at
baseline (paired t-test): #P  0.05.
Differences between remitted participants at follow-up and healthy controls (t-
test): *P  0.05.
a Event frequencies are reported as percentages of the total number of valid ESM
reports.NA levels in non-remitted participants were also unchanged at
follow-up compared to baseline (2.7 vs 3.1, t (18) = 2.01, P = 0.06).
In remitted participants, mean PA remained signiﬁcantly lower
than in healthy controls (3.6 vs 4.5, t (48) = 3.03, P = 0.004), and
mean NA was signiﬁcantly higher (1.7 vs 1.3, t (48) = 2.93,
P = 0.005). The level of residual depressive symptoms could explain
these differences in mean NA and PA, as the post-treatment HDRS
score was associated with higher mean NA (rs = 0.68, n = 11,
P = 0.02) and lower mean PA (rs = –0.63, n = 11, P = 0.04) levels
among remitted depressed participants.
3.4. Stress reactivity at 18-month follow-up
Multilevel regression estimates of post-treatment stress
reactivity to negative events (with associated appraisals), activity
stress, and social stress are presented in Table 3.
Positive affect: the occurrence of negative events, social stress
and activity stress were all associated with reductions in PA.
Appraised unpleasantness, importance and stressfulness of nega-
tive events had no additional effects on PA. Further, the severity of
depressive symptoms at follow-up (HDRS score) was not a
signiﬁcant predictor of the stress-related decrease in PA (all three
stress types).
Negative affect: negative events, activity stress, and social
stress were all accompanied by signiﬁcant increases in NA. The
increase in NA after negative events and activity stress was in both
cases dependent on the severity of residual depressive symptoms
at 18 months: higher HDRS scores were associated with higher
increases in NA following stress. This was not the case for social
stress, however: here, NA-reactivity was independent of the
severity of depressive symptoms. Negative events that were
appraised as more stressful were associated with further increases
in NA; in contrast, appraised unpleasantness and importance of
negative events had no effect on NA.
3.5. Stress reactivity in remitted and non-remitted depressed
participants compared to healthy controls
Results of comparisons of stress responses at follow-up
in remitted and non-remitted depressed patients with those
in healthy controls (the reference group) are presented in
Table 4.
Positive affect: the extent to which PA was lower in the context of
negative events, activity stress, and social stress was similar in
healthy controls, remitted, and non-remitted depressed partici-
pants.Table 3
Multilevel estimates of the main effects of daily stress (negative event, activity, and
social stress) at 18-month follow-up and the interaction effects of daily stress with
Hamilton Depression Rating Scale (HDRS) on positive and negative mood states.
PA NA
Main effects
Negative event B = –0.301, P = 0.001 B = 0.522, P < 0.001
Unpleasantness B = 0.022, P = 0.678 B = 0.023, P = 0.577
Importance B = –0.022, P = 0.480 B = –0.027, P = 0.260
Stressfulness B = –0.071, P = 0.191 B = 0.165, P < 0.001
Activity stress B = –0.189, P < 0.001 B = 0.169, P < 0.001
Social stress B = –0.112, P < 0.001 B = 0.162, P < 0.001
Interactions
Negative event  HDRS B < 0.001, P = 0.976 B = 0.020, P = 0.029
Activity stress  HDRS B = 0.006, P = 0.176 B = 0.006, P = 0.026
Social stress  HDRS B = 0.003, P = 0.435 B = –0.001, P = 0.730
B: unstandardized beta.
Table 4
Multilevel estimates of daily stress (negative event, activity, and social
stress)  group (non-remitted and remitted MDD patients at follow-up and healthy
controls) on positive and negative mood states (PA and NA).
Groups (with
healthy controls
as the reference
group)
Type of stress PA NA
Non-remitted
Remitted
Negative event
B = –0.106, P = 0.289
B = –0.066, P = 0.589
B = 0.255, P = 0.012
B = 0.085, P = 0.501
Non-remitted
Remitted
Activity stress
B = –0.010, P = 0.825
B = –0.083, P = 0.126
B = 0.087, P = 0.003
B = 0.038, P = 0.283
Non-remitted
Remitted
Social stress
B = 0.034, P = 0.387
B = –0.059, P = 0.192
B = 0.103, P = 0.005
B = 0.117, P = 0.004
B: unstandardized beta. This table shows an interaction between daily stress
(negative event, activity, and social stress) and group (non-remitted, remitted and
healthy controls) with PA and NA as outcome measurements in order to examine
whether the patient groups differ from healthy controls with respect to stress
reactivity. Thus, non-remitted and remitted MDD patients were compared with
healthy controls (the reference group).
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Fig. 1. Comparison of social stress reactivity in healthy controls, non-remitted, and
remitted MDD patients, with NA as outcome measurement. *Signiﬁcant differences
(*P  0.05) in effect sizes for very unpleasant appraisals of company (effect of social
stress on negative affect) between remitted and healthy controls. #Signiﬁcant
differences (#P  0.05) in effect sizes for very unpleasant appraisals of company
(effect of social stress on negative affect) between non-remitted and healthy
controls.
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signiﬁcantly higher NA in relation to all three types of stress,
compared to healthy controls. In contrast, remitted depressed
participants did not differ from healthy controls in NA-reactivity to
self-reported negative events and activity stress. In the case of
social stress, remitted participants still reported signiﬁcantly
higher NA than healthy controls. Fig. 1 shows the levels of NA at
different levels of social stress, stratiﬁed by group. The dose-
response relationship between social stress and NA was more
pronounced in the depressed groups. Differences in effect sizes
between non-remitted and healthy controls were signiﬁcant for
average (B = 0.703, P < 0.001) and above average (B = 0.558,
P = 0.017) appraisals of social stress. Remitted participants differed
from healthy controls for average (B = 0.763, P = 0.001), above
average (B = 0.677, P = 0.045) and strong appraisals of social stress
(B = 0.645, P = 0.040).
4. Discussion
The current paper examined, with the use of ESM, differences
in negative event frequency, appraisals, momentary mood states,
and stress levels between healthy controls and remitted
depressed participants after a naturalistic treatment period of
18 months. In addition, the follow-up results for non-remitted
participants were compared with their own pre-treatment levels.
Further, we tested the moderating role of residual depressive
symptoms on stress reactivity to three types of stress (event-,
activity-, and social stress). Last, we examined differences in
stress reactivity between non-remitted, remitted, and healthy
control groups.
Results showed that participants with non-remitted com-
pared to remitted depression appraised negative events as more
stressful. NA was higher in the context of recent negative events
and activity-stress, dependent on the severity of current
depressive symptoms. Of note, relatively high NA in relation to
social stress at follow-up was independent of the severity of
depressive symptoms. In comparison with healthy controls,
remitted depressed participants continued to show a heightened
sensitivity to social stress only, whereas non-remitted depressed
participants showed greater NA-reactivity in relation to all three
types of stress.4.1. Changes and differences in event frequencies, stress appraisals
and mood states
In many respects, remitted participants could not be distin-
guished from healthy controls: their stress levels and event
frequencies appear to have normalized. However, participants
with remitted depression still showed signiﬁcantly lower mean PA
and higher mean NA levels compared to healthy, never-depressed
individuals. This may serve as support for recent work showing
that clinical remission based on current cut-off scores does not
imply restoration of pre-morbid functional capacities in different
life domains [47].
Non-remitted depressed participants demonstrated some
signiﬁcant changes in negative event frequencies, stress levels
and mean NA/PA levels in comparison with their own baseline
levels. These event frequencies are in line with the baseline event
frequencies reported in an earlier study in this sample [32].
4.2. Moderating effect of residual symptoms on stress reactivity
Until now, virtually no data were available on changes in
stress reactivity in depressed individuals post-treatment. As we
had expected, all three types of daily stress (event-, activity-, and
social stress) were associated with lower PA and higher NA,
compared to non-stress contexts. Furthermore, the increase in
NA after event- and activity-stress was dependent upon the
severity of residual depressive symptoms. The moderating effect
of severity of depressive symptoms on NA-reactivity to event-
and activity-related stress suggests that the increased NA-
reactivity to these types of stress is state-dependent. This is in
line with a study that showed that NA-reactivity to activity stress
decreased only in clinically improved participants after six weeks
of treatment with imipramine or placebo [44]. A novel ﬁnding
was that the increase in NA after social stress was independent of
the severity of persistent depressive symptoms. This may be
indicative of a pre-morbid and/or acquired sensitivity to social
stress in subjects with MDD, which is not related to the level of
current symptomatology.
4.3. Stress reactivity compared to healthy controls
4.3.1. Event- and activity stress
The increased NA-reactivity to activity-related stress in non-
remitted depressed participants was signiﬁcant higher than in
healthy never depressed individuals. This ﬁnding is in concordance
with the study of Wichers et al. (2009). Taken together, these
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a stable phenotype when an episode of MDD becomes chronic.
Concerning the stronger event-related stress reactivity in non-
remitted depressed participants in comparison with healthy
controls, it should be noted that the impact of stress on NA
actually depends upon the appraised stressfulness of the event.
Previous ESM reports also reported this mediating role of the level
of stressfulness of an event on mood reactivity [10,32]. Although
Bylsma et al. [10] and Peeters et al. [32] reported respectively a
normal or blunted stress reactivity in depressed patients compared
to healthy controls, they also examined the relationship between
the appraised stressfulness and stress reactivity to negative events.
They both found greater increases in NA as subjective appraisals of
stressfulness increased in depressed patients. Peeters et al. (2003)
concluded that their results can be interpreted as ‘‘evidence for
environmental hypersensitivity (event appraisals) and on the
other hand (mood changes), they may be construed as evidence for
hyposensitivity’’ [32].
4.3.2. Social stress
Remitted depressed participants remained more sensitive to
experiences of social stress than healthy controls, although event-
and activity-related stress reactivity normalized. This ﬁnding
cannot be explained by the presence of residual symptoms, as
social stress related increases of NA were independent of severity
of depressive symptoms. There exist several explanations for
these ﬁndings. First, this increased sensitivity may be perceived as
indicative of a ‘‘scar’’ in stress reactivity as a result of the
experience of an episode of MDD [45,24,5]. However, a scarring
effect seems less likely because one would expect such effect on all
three types of stress reactivity that we examined and not only on
social stress. Unfortunately no pre-morbid data from our
participants are available to test this hypothesis. An alternative
possibility to investigate this hypothesis would be to examine
whether social stress reactivity increases as a function of more
depressed episodes. Unfortunately, our sample size is underpow-
ered for such analysis. Second, it has also been suggested that
increased NA-reactivity to social stress puts people at risk for
developing MDD or recurrence [4,13,43,30]. As such, increased
social stress reactivity may be conceived as a proxy for other risk
factors that are known to play a role in the development of MDD
such as neuroticism [28,2,25] and increased self-esteem liability
[8,35,34,11]. Further, in favour of a pre-morbid vulnerability,
there is emerging evidence that increased NA-reactivity to social
stress is indicative of a genetic predisposition to respond with
more NA to small social stressors and may function as an
intermediate endophenotype of MDD [43,42,29,27]. More specif-
ically, speciﬁc variations of the BDNF gene, Met carriers of the
BDNF Val66Met genotype, are associated with a higher NA-
reactivity to social stress [43,42]. This is in line with evidence
that sensitivity to perceived social stress is an important
vulnerability factor in teenagers that develop depression at a
later stage [39].
Our current paper supports the notion that daily life increased
NA-reactivity to social stress is an important endophenotype in the
course of MDD, which may increase risk for the development and
recurrence of a depressive episode. Future research should
contribute to a better understanding of the speciﬁc role of social
stress reactivity in daily life in the risk for and relapse in MDD.
4.3.3. Discrepancies between ﬁndings from experimental and daily life
studies
Stress reactivity in experimental studies is mainly induced with
the use of ﬁlms, pictures or emotional imagery. Grillon et al. [21]
argued that the threat in these procedures is typically mild,
hypothetical and/or may lack personal relevance. Other authorshave also pointed to the fact that stressors may be experienced
differently by each subject, depending on the meaning the
situation has for this particular individual [6,37]. This might
explain why some daily life studies found increased stress
reactivity instead of blunted stress reactivity. It may be suggested
that blunted stress reactivity in case of hypothetical and non-
personal threats and increased stress reactivity in case of personal
relevant threats coexist in MDD [21].
4.4. Strengths and limitations
Our study has several strengths. To our knowledge this is the
ﬁrst study to examine stress reactivity to various minor daily
stressors before and after a naturalistic MDD treatment. Secondly,
because our study was based on a substantial follow-up period
(18 months), we were able to examine stress reactivity in
participants who were in a period of stable remission compared
to those with more chronic depression. This is of particular
importance because it was unclear whether clinical improvement
was accompanied by normalization of daily stress reactivity.
Some limitations also apply. Although the multiple measure-
ments derived from the ESM and modelled with multilevel
regression techniques afforded sufﬁcient statistical power to
detect differences in daily life stress reactivity, our relatively
small sample size warrants replication in larger samples. Next, due
to the small number of remitted participants we were not able to
test pre-to-post individual differences in stress reactivity. Further,
we did not use a structured interview (SCID-I) at follow-up, but
instead relied on a cut-off score of 7 on the 17-item HDRS to deﬁne
remission from MDD, as recommended in literature. Therefore, it is
uncertain if our results apply to subjects whose remission status is
assessed with a formal diagnostic interview. Further, the fact that,
in addition to psychotherapy, all participants underwent antide-
pressant treatment according to current practice guidelines (APA,
[1] means that antidepressants may have inﬂuenced ESM stress-
reactivity measurements). An earlier ESM study showed that
treatment with antidepressants, in comparison to placebo,
signiﬁcantly decreased NA-reactivity to activity stress after six
weeks [44]. Also, even with a time-sampling approach like ESM,
retrospective biases cannot be entirely eliminated, given that
participants reported negative events over 90 min intervals.
Furthermore, causal associations between events and mood states
cannot be conclusively determined, because event and affect
reports were collected simultaneously. However, in support of our
assumption that events most likely inﬂuenced emotions (and not
vice versa), we previously reported that prior events at baseline in
the same sample, controlling for effects of current events, were
associated with persistent changes in PA and NA [32]. Further, no
reliability data on diagnoses with the use of SCID interview are
available. A research psychiatrist (FP) assessed all SCID interviews.
No other raters were involved.
Last, NA and PA were rated at the same moment that activity
and social stress were assessed. This is in contrast with the
assessment of small negative events, which may have occurred
maximally 90 minutes before mood assessment. As a result of this
delay, we cannot rule out an underestimation of the association
between negative events and mood in comparison to mood
responses associated with the two other types of stress. In
conclusion, the current ﬁndings suggest that greater stress
reactivity to negative events and stressful daily activities may
be a state-dependent characteristic of MDD, normalizing upon
remission. Heightened stress reactivity to social contexts, on the
other hand, was observed in remitted as well as in non-remitted
patient groups, suggesting that sensitivity to social stress may
reﬂect an underlying vulnerability for development and recurrence
of MDD.
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